LAVERDIA-CA1 (verdinexor) binds to XPO1 to prevent the transport of tumor suppressor proteins (TSPs) from the nucleus of cells. TSPs then trigger apoptosis and slow the rapid replication of cancer.
The Science Behind SINE Class DrugsRegister Now
Read Peer-Reviewed Papers About SINELearn More
Waiting for SpecialistDon't let days pass without treatment. Use LAVERDIA-CA1 to help prevent further advancement of cancer before chemotherapy starts. Unlike prednisone, LAVERDIA-CA1 does not create resistance to cytotoxic drugs and can sensitize cancer cells to improve response to therapy.
Stopped ChemotherapyLAVERDIA-CA1 can be used as a rescue therapy for patients that have relapsed or cannot continue traditional chemotherapy due to side effects. Three tablet strengths allow for precise dosing that maximizes therapeutic benefit while minimizing side effects.